BSFA.STU ANI Pharmaceuticals Inc

Healthcare Pharmaceuticals Stuttgart Exchange
64.53 EUR
Close of Nov 1, 2026
59.50 81.00
Market cap
EUR 1.48B
P/E
16.3x
P/B
2.77x
ROE
18.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is BSFA.STU undervalued?

Graham number
Price64.53
Graham value45.54
Premium41.7%

BSFA.STU trades 41.7% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

ANI Pharmaceuticals Inc fundamental analysis

No fundamental analysis for ANI Pharmaceuticals Inc yet.

ANI Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About ANI Pharmaceuticals Inc

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. The company manufactures oral solid dose products; semi-solids, liquids, and topicals; controlled substances; and potent products, as well as performs contract development and manufacturing of pharmaceutical products. It markets its products through retail pharmacy chains, wholesalers, distributors and m…

Full company profile